Comparative Tolerability of Protease Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Korean Post-marketing Surveillance for Reyataz®
- Status
- COMPLETED
- Phase
- N/A
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials
- Status
- COMPLETED
- Phase
- PHASE2
Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
- Status
- COMPLETED
- Phase
- PHASE3
Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials
- Status
- COMPLETED
- Phase
- PHASE2
Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin
- Status
- TERMINATED
- Phase
- PHASE2
Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of SAR302503 in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Electronic Decision Support Systems for Smokers With Severe Mental Illness
- Status
- COMPLETED
- Phase
- NA
Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
- Status
- COMPLETED
- Phase
- PHASE4
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2